The next generation of breast cancer detection technologies is not being built solely on private capital. In many cases, it is being financed through federal research infrastructure designed to move high-risk innovation toward commercialization.

Anthropic, a prominent artificial intelligence start-up, said on Thursday that it had completed a new funding round that valued the company at $380 billion, more than doubling its valuation since its last funding round in September.